HIGHLIGHTS
- who: Xiao Wang et al. from the Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Health System have published the article: A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma, in the Journal: PLOS ONE of 18/Nov/2021
- what: The aim of the study was to assess the outcomes of patients receiving neoadjuvant chemotherapy compared to those receiving adjuvant or no perioperative chemotherapy. The study demonstrates that neoadjuvant chemotherapy is a safe and viable treatment option for patients with DMPM. Prospective studies are necessary, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.